Imperial Innovations sells Respivert
Imperial Innovations has sold Respivert for £9.5 million to US firm Centocor Ortho Biotech.
News
Imperial Innovations has sold Respivert for £9.5 million to US firm Centocor Ortho Biotech.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software